Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.13 USD | -1.85% | +4.30% | -6.20% |
08/05 | Stifel Adjusts Price Target on Denali Therapeutics to $22 From $26, Maintains Hold Rating | MT |
08/05 | Wedbush Adjusts Denali Therapeutics' Price Target to $30 From $31, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.20% | 292.49Cr | |
+9.58% | 11TCr | |
+12.41% | 11TCr | |
-2.59% | 2.2TCr | |
-12.38% | 2.19TCr | |
-5.29% | 1.92TCr | |
-3.35% | 1.81TCr | |
-38.57% | 1.77TCr | |
+7.51% | 1.43TCr | |
+35.67% | 1.24TCr |
- Stock Market
- Equities
- DNLI Stock
- News Denali Therapeutics Inc.
- Wedbush Adjusts Denali Therapeutics' Price Target to $30 From $31, Keeps Outperform Rating